Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001562180-20-006656

Director sold 10,000 shares at an average $301.99 ($3,019,948)

  • Director acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
STEER RANDOLPH C Director 2020-11-06 Option exercise +5,000 $70.35 $351,750 10,112 D: show line 1 in the form
STEER RANDOLPH C Director 2020-11-06 Option exercise +5,000 $66.90 $334,500 15,112 D: show line 2 in the form
STEER RANDOLPH C Director 2020-11-06 Sale −1,723 $299.06 $515,280 13,389 D: show line 3 in the form
STEER RANDOLPH C Director 2020-11-06 Sale −1,771 $299.96 $531,229 11,618 D: show line 4 in the form
STEER RANDOLPH C Director 2020-11-06 Sale −1,801 $301.78 $543,506 9,817 D: show line 5 in the form
STEER RANDOLPH C Director 2020-11-06 Sale −1,195 $302.31 $361,260 8,622 D: show line 6 in the form
STEER RANDOLPH C Director 2020-11-06 Sale −975 $304.14 $296,537 7,647 D: show line 7 in the form
STEER RANDOLPH C Director 2020-11-06 Sale −2,535 $304.59 $772,136 5,112 D: show line 8 in the form
Open-market sales · 10,000 sh · avg $301.99 · $3,019,948

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
STEER RANDOLPH C Director 2020-11-06 Option exercise · Stock Option (Right to Buy) −5,000 0 D: show line 9 in the form
STEER RANDOLPH C Director 2020-11-06 Option exercise · Stock Option (Right to Buy) −5,000 0 D: show line 10 in the form
Loading xslF345X03/primarydocument.xml…